Bio

Timothy Swan advises technology companies on practical approaches to fit their specific needs and goals. He represents clients through a variety of technology transactions, most frequently in the areas of life sciences, healthcare IT and information technology. He also helps clients of all sizes on both buy and sell-side M&A transactions, with a focus on life science, software and other IP and technology dependent targets. In addition, Tim shepherds companies and investors through financings, including convertible notes, SAFEs and preferred equity rounds, and corporate governance matters. Tim represents companies ranging from startups and emerging companies, to large clients. He has extensive experience preparing and negotiating licensing, collaboration, joint venture, development, professional services, contract research, manufacturing, clinical trial and other technology-related agreements, as well as the various flavors of financing rounds. Having worked with private equity and venture capital funds, and having advised numerous of their portfolio companies, Tim is able to succinctly counsel life science and technology companies as they navigate the unique dynamics of their relationships with investors and owners.